Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
9.47
-0.80 (-7.79%)
At close: May 22, 2026, 4:00 PM EDT
9.61
+0.14 (1.48%)
After-hours: May 22, 2026, 7:07 PM EDT
Telix Pharmaceuticals Employees
As of December 31, 2025, Telix Pharmaceuticals had 1,184 total employees, including 1,120 full-time and 64 part-time employees. The number of employees increased by 950 or 405.98% compared to the previous year.
Employees
1,184
Change
950
Growth
405.98%
Revenue / Employee
$678,880
Profits / Employee
-$6,018
Market Cap
3.22B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,184 | - | - | 1,120 | 64 |
| Mar 31, 2024 | 431 | 197 | 84.19% | 415 | 16 |
| Dec 31, 2022 | 234 | 76 | 48.10% | 234 | 0 |
| Dec 31, 2021 | 158 | - | - | 158 | 0 |
| Dec 31, 2017 | 9 | - | - | 9 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 522 |
| Denali Therapeutics | 507 |
| Dyne Therapeutics | 263 |
| Relay Therapeutics | 193 |
| Edgewise Therapeutics | 154 |
| Tango Therapeutics | 137 |
TLX News
- 2 days ago - Telix Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 2 days ago - Telix Pharmaceuticals Slides: FY 2026 - Filings
- 2 days ago - Telix Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 2 days ago - Telix Pharmaceuticals Slides: FY 2026 - Filings
- 4 days ago - IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing - GlobeNewsWire
- 7 days ago - EDAP Explores Collaboration with Telix Pharmaceuticals on Prostate Cancer Treatments - GuruFocus
- 7 days ago - Telix, EDAP And Profound Partner To Explore PSMA-PET Imaging In Prostate Cancer Treatment - Nasdaq
- 8 days ago - Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches - GlobeNewsWire